Table 55:

Budget Impact Analysis Results, nVNS for Prevention, Cluster Headache

Scenario	Budget impact, $ milliona
	Year 1	Year 2	Year 3	Year 4	Year 5	Totalb,c
Current scenario	29.83	30.50	31.04	31.47	31.924	154.765
Acute medication costs	20.40	20.83	21.23	21.52	21.83	105.83
Prevention medication costs	7.11	7.27	7.40	7.50	7.60	36.90
Monitoring costs	2.32	2.37	2.41	2.45	2.482	12.03
New scenario
Standard care alone	29.53	29.89	30.11	30.21	30.27	150.07
Acute medication costs	20.19	20.46	20.59	20.66	20.74	102.62
Preventive medication costs	7.04	7.13	7.18	7.20	7.23	35.78
Monitoring costs	2.30	2.32	2.34	2.35	2.36	66.57
nVNS + standard care	0.93	1.90	2.90	3.92	4.97	14.62
nVNS costs	0.76	1.54	2.36	3.19	4.04	11.88
Acute medication costs	0.079	0.16	0.25	0.33	0.42	1.24
Preventive medication costs	0.071	0.15	0.22	0.30	0.38	1.12
Monitoring costs	0.023	0.047	0.072	0.098	0.12	0.37
Budget impactb,c	0.63	1.29	1.97	2.66	3.37	9.92
nVNS costs	0.76	1.54	2.36	3.19	4.04	11.88
Acute medication costs	-0.12	-0.26	-0.39	-0.53	-0.67	-1.96
Preventive medication costs	0.00	0.00	0.00	0.00	0.00	0.00
Monitoring costs	0.00	0.00	0.00	0.00	0.00	0.00

Abbreviation: nVNS; noninvasive vagus nerve stimulation.

^aIn 2024 Canadian dollars.

^bNegative costs indicate savings.

^cResults may appear inexact due to rounding.